Diamond et al., Double-blind, Placebo-Controlled Evaluation of the Safety, Pharmacokinetic Properties and Pharmacodynamic effects of Intranasal PT-141 , a Melanocortin Receptor Agonist, in Healthy Males and Patients with Mild-to-Moderate Erectile Dysfunction
This work supports and extends our recent study showing that GLP-1 from the OB also controls the odour-evoked cephalic phase of insulin secretion 16
Validated mapping places the receptor in the arcuate and paraventricular nuclei of the hypothalamus, the area postrema, and the nucleus of the solitary tract in the brainstem, regions that govern hunger, satiety, and nausea
Psychological monitoring is an often-overlooked but critical component of adolescent GLP-1 therapy, as teenagers may experience mood changes, concerns about medication dependency, or body image shifts as they lose weight
A 200 lb man who drinks the same 2 drinks reaches approximately 0.04%